La 5^ edizione del Festival dell’Innovazione e della Scienza di Settimo T.se, è dedicata quest’anno alla Chimica. OLON SpA ha quindi inteso contribuire attivamente come sponsor dell’evento e ha deciso di aprire le porte dello stabilimento di Settimo T.se a tutto il pubblico interessato a visitarlo nelle giornate di chiusura del Festival, ovvero sabato 21 e domenica 22 ottobre.

Lo storico stabilimento nato nel 1907 come Schiapparelli Farmaceutici (noto anche come Farmitalia Carlo Erba o Antibioticos), compie 110 anni e, per l’occasione, intende fornire al pubblico un’opportunità sicuramente interessante per chiunque voglia comprendere meglio come si svolge la ricerca, lo sviluppo e la produzione, di alcuni principi attivi farmaceutici appartenenti alle classi degli antibiotici e degli antitumorali.

Le visite saranno organizzate in 10 turni di circa 90’ (con inizio alle ore 9, 11, 14, 16, e 18), distribuiti nelle due giornate di sabato 21 e domenica 22 ottobre 2017. Chi vorrà prenotarsi potrà farlo telefonando al numero 011-8966389, oppure mandando una mail all’indirizzo infofabbricheaperte@olonspa.it.

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA)

Acquisition strengthens service offering of global CDMO and Generics provider for research and manufacturing

Milan (Italy) – June 9, 2017 Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, announced today the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry, and to benefits the Ricerca Biosciences customer base by providing large scale manufacturing capabilities in Europe.

Paolo Tubertini, CEO of Olon, commented, "By acquiring a research and manufacturing base in the US, Olon will have the opportunity to accelerate growth by adding new CDMO projects and to develop new Generic products for the American market." Luca Mantovani, OLON Managing Board member, added, "We are delighted to add Ricerca Biosciences to Olon Group, as this strategic step will broaden our contract research and manufacturing services for all our global customers". No financial details were disclosed.

About Ricerca
Ricerca Biosciences is a US-based CRO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution.  Ricerca’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first-time scale-ups and subsequent development of safe, reliable, robust and cost effective manufacturing processes.    Meeting client needs has been the foundation of Ricerca’s business philosophy and is second only to its commitment to safety and regulatory compliance. www.ricerca.com